| Leucine | |
|---|---|
| IUPAC name | |
| Identifiers | |
| CAS number | [] |
| PubChem | |
| SMILES | |
| Properties | |
| Molecular formula | C6H13NO2 |
| Molar mass | 131.17 g mol−1 |
| Supplementary data page | |
|
Structure and properties |
n, εr, etc. |
|
Thermodynamic data |
Phase behaviour Solid, liquid, gas |
| Spectral data | UV, IR, NMR, MS |
|
Except where noted
otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox references |
|
Leucine (abbreviated as Leu or L)[1] is an α-amino acid with the chemical formula HO2CCH(NH2)CH2CH(CH3)2. It is an essential amino acid, which means that humans cannot synthesise it. Its codons are UUA, UUG, CUU, CUC, CUA, and CUG. With a hydrocarbon side chain, leucine is classified as a hydrophobic amino acid. It has an isobutyl R group. Leucine is a major component of the sub units in ferritin, astacin and other 'buffer' proteins.
As an essential amino acid, leucine is not synthesized in animals, hence it must be ingested, usually as a component of proteins. It is synthesized in plants and microorganisms via several steps starting from pyruvic acid. The initial part of the pathway also leads to valine. The intermediate α-ketovalerate is converted to α-isopropylmalate and then β-isopropylmalate, which is dehydrogenated to α-ketoisocaproate, which in the final step undergoes reductive amination. Enzymes involved in a typical leucine biosynthesis include[2]
As a dietary supplement, leucine has been found to slow the degradation of muscle tissue by increasing the synthesis of muscle proteins in aged rats.[3] Leucine is utilized in the liver, adipose tissue, and muscle tissue. In adipose and muscle tissue, leucine is used in the formation of sterols, and the combined usage of leucine in these two tissues is seven times greater than its use in the liver.[4]
Leucine toxicity, as seen in decompensated Maple Syrup Urine Disease (MSUD), causes delirium and neurologic compromise, and can be life-threatening.
In yeast genetics, mutants with a defective gene for leucine synthesis (leu2) are transformed with a plasmid that contains a working leucine synthesis gene (LEU2) and grown on minimal media. Leucine synthesis then becomes a useful selectable marker.
Racemic leucine had been subjected to circularly polarized synchrotron radiation in order to better understand the origin of biomolecular asymmetry. An enantiomeric enhancement of 2.6 % had been induced, indicating a photochemical origin of biomolecules' homochirality.[5]
As a food additive, L-Leucine has E number E641 and is classified as a flavour enhancer.